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Abstract
Background: The question of whether intact somatic cells committed to a specific differentiation fate, can be
reprogrammed in vivo by exposing them to a different host microenvironment is a matter of controversy. Many reports on
transdifferentiation could be explained by fusion with host cells or reflect intrinsic heterogeneity of the donor cell
population.
Methodology/Principal Findings: We have tested the capacity of cloned populations of mouse and human muscle
progenitor cells, committed to the myogenic pathway, to transdifferentiate to neurons, following their inoculation into the
developing brain of newborn mice. Both cell types migrated into various brain regions, and a fraction of them gained a
neuronal morphology and expressed neuronal or glial markers. Likewise, inoculated cloned human myogenic cells
expressed a human specific neurofilament protein. Brain injected donor cells that expressed a YFP transgene controlled by a
neuronal specific promoter, were isolated by FACS. The isolated cells had a wild-type diploid DNA content.
Conclusions: These and other results indicate a genuine transdifferentiation phenomenon induced by the host brain
microenvironment and not by fusion with host cells. The results may potentially be relevant to the prospect of autologous
cell therapy approach for CNS diseases.
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Introduction
Recent studies showed that a variety of somatic cell types can be
reprogrammed into pluripotent cells (iPS cells), closely resembling
embryonic stem cells, by exposing their genome to transcription
factors which activate endogenous genes involved in the
maintenance of stem cells pluripotency [e.g. 1]. Yet, the question
of whether genetically unmodified intact cells that are already
committed to a specific differentiation default can be repro-
grammed to a different fate by ectopic microenvironmental cues, is
still a matter of controversy [e.g. 2–4]. Many reported cases of
transdifferentiation following inoculation of cells into a suitable
host tissue could be explained on the basis of fusion with a host cell
committed to a different differentiation program, which overrides
the program of the donor cell [5,6]. In addition, data accumulated
indicate the prevalence of multipotent stem cells in many adult
tissues. Therefore, the apparent plasticity could, in some cases, be
due to the differentiation of uncommitted cells which originated
from the donor tissue.
Muscle progenitor cells (MPCs) are an easily accessible cell
type with well-characterized markers associated with its various
differentiation stages. It is also relatively simple to clone and
manipulate them in culture; thus offering a convenient model
system to study the differentiation plasticity of mammalian cells.
Muscle progenitor cells are also promising candidates for the
treatment of muscle degenerative diseases and perhaps also as a
source for replacement of other cell types, provided that they can
be reprogrammed into different fates. The mononucleated
progenitors of the skeletal muscle, the myoblasts of the growing
muscle, were among the first examples to demonstrate the
extreme stability of a differentiation program. Clonal analysis in
cell culture showed the stable retention, during many cell
generations, of a committed program of self renewal and a
default for myogenic terminal differentiation [7–9]. There have
been several reports on the isolation of cells from muscle tissue
that are capable of differentiation into a variety of cell types
including neuron-like cells. However, in those cases the donor
cells seemed to contain subpopulations of cells not committed to
the myogenic lineage, that reside in skeletal muscle [10–15]. In
view of the importance of the basic biological question, and its
possible relevance to the prospect of cell therapy, we examined
this question by using characterized cloned populations of
myogenic cells expressing the muscle specific transcription factor
MyoD, and manifesting the default to differentiate into muscle
fibers and to participate in muscle regeneration [16]. Such mouse
myogenic cells and cloned human myoblasts were inoculated into
the developing brain of newborn mice. We have found that a
significant fraction of the inoculated cells spread in the brain and
transdifferentiated into neuronal-like cells expressing neuronal
markers, without fusion with host cells, thus indicating a genuine
transdifferentiation process induced by the host developing brain
environment.
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Ethics Statement
Research involving human participants was approved by the
Helsinki Committee (H.C.) of the Israeli Ministry of Health and by
the Kaplan Hospital H.C. Clinical investigations (muscle biopsies)
have been conducted according to the principles expressed in the
Helsinki Declaration. All patients provided written informed
consent as approved by the Helsinki Committee of the Israeli
Ministry of Health and by the Kaplan Hospital H.C.
All animal work has been conducted according to the
Weizmann Institute of Science’s Institutional Animal Care and
Use Committee (IACUC) and International Guidelines.
Cell Culture
Mouse muscle progenitor cells were prepared as previously
described [16]. Cells were passaged every 3 days or kept
frozen. Cells from the 10–15 passages were used in the present
investigation. Several clones were obtained from ROSA26 mice,
which contain a transgene encoding a ubiquitously expressed
bacterial b-galactosidase [17]. Other clones were derived from the
Thy1-YFP 2.2 mice, which express YFP under a neuronal specific
promoter [18]. The mouse myosphere clones that were used in the
present study for intra-brain injection reproducibly gave rise to
cells that spread and transdifferentiated as described later.
Preliminary screening revealed some myosphere derived clones
that did not yield transdifferentiating cells following their
inoculation into the newborn brains. These clones were not used
for the present study.
Human muscle biopsies (two patients; each biopsy less than one
cm
3) were taken by an orthopedic surgeon during surgery of bone
or muscle, performed due to reasons unrelated to the biopsies for
the current research.
The biopsies were dissociated as described for mouse muscles
[16]. Several fractions of cells were collected by differential plating
[8] on the basis of their adhesion properties. The fraction of cells
that attached to the plates between 2 to 18 hrs after plating
consisted of almost pure population of myogenic cells and was
used for the preparation of primary human myoblasts cultures. For
cloning, cells were diluted and plated at ,2 cells/cm
2. Colonies
originating from single cells were collected, and propagated on
gelatin coated plates. The work with human muscles was approved
by Helsinki Committee of the Israeli Ministry of Health.
Cells Transplantation into the Brain of Mice
Cloned cells were collected by trypsinization, washed with
phosphate-buffered saline (PBS), and re-suspended at a concen-
tration of 10
5 cells/1.5 ml in cold PBS. Three day old C57BL mice
were anesthetized, and 10
5 cells were injected into their brain
lateral ventricles, using a Hamilton syringe. Human cells were
labeled with Hoechst prior to injection; the cells were suspended
for 10 min at 37uC in PBS containing 0.02 mM Hoechst, and
washed 3 times with PBS. Mice were sacrificed at the indicated
time points, and their brains were removed for further analysis.
The brains were fixed with 2.5% Paraformaldehyde (PFA) for
2–3 hours, transferred to 15% sucrose solution with 1% PFA, and
incubated at 4uC for not less than 16 hrs. Sagittal brain slices of
25–40 mm were collected using sliding microtome (Leica SM
2000r). Five to seven mice were injected in each experiment. At
least 3 brains were thoroughly sectioned and analyzed. The brain
inoculations of b-gal marked mouse myosphere cells experiments
were repeated at least 3 times and the injection of human
myoblasts experiments were repeated twice.
X-Gal Staining. Slices were washed with PBS and stained
overnight at 37uc with X-gal solution, as previously described [19].
Slices were washed with PBS, and counterstained with nuclear
fast red.
Immunochemistry
Cell cultures. Adherent cells were grown on gelatin or
fibronectin coated glass cover slips. The immunostaining was done
as previously described [16]. Pictures were taken with a 1310
digital camera (DVC).
Brain slices. Sections adjacent to X-gal positive slices were
selected for immunohistochemical analysis. Slices were blocked
and stained using M.O.M kit solutions (Vector, U.K). The slices
were incubated over-night at room temperature with anti-b-gal
(1:200, Sigma-Aldrich, IL) together with one of the following
antibodies: anti Doublecortin (1:100, Santa-Cruz Biotechnology,
Inc., CA, U.S.A), Tuj1 (1:400, Covance, CA, U.S.A), NF-160
(1:800, Abcam, U.K), NeuN (1:200, Chemicon, CA, U.S.A).
Secondary antibodies were either used for direct detection (Cy3
anti-mouse for the b-gal labeling), or with biotin-streptavidin-
FITC for the neuronal markers. Slices were stained with DAPI
solution for 2 min, air-dried and mounted as above. For the
detection of NeuN, X-gal stained slices were labeled with anti-
NeuN and detected with Vectastain ABC Kit (Vector, U.K).
Brains injected with human cells were sliced, and slices containing
Hoechst labeled cells were immunostained with the human specific
anti-NF 70 Ab (1:100, Chemicon, CA, U.S.A).
FACS Analysis
For each experiment, one litter of 6–7 newborn mice was used.
Brains were removed one week after injection of donor cells, and
suspended according to Roy et al., [20]. As most of the injected
cells did not reach the cerebellum it was removed, and the
remaining brain was minced with a scalpel, and then transferred
into a solution containing 11.5 U/ml papain (preinduced with
cysteine), and DNase (10 u/ml). The samples were rotated for
30 min at 37uC. Brains of 6–7 non-injected newborn mice served
as a control. The cells were collected, and re-suspended in PBS.
Hoechst was added (0.02 mM), and the cells were incubated for
10 min at 37uC, washed twice with PBS, and re-suspended at a
concentration of 10
7 cells/0.5 ml.
10
4 cells of the main population were collected from each
sample, to determine the cell-cycle of host neuronal cells. The rest
of the population was sorted, and only the gated, YFP positive cells
were collected, and cell-cycle analyzed. The experiments were
done using either FACSVantage or LSR FACS (BD).
Results
Muscle Progenitor Cells Express Neuronal Markers
Following Inoculation into the Brain of Newborn Mice
We have previously described the isolation and propagation of a
population of myogenic cells, from adult mouse skeletal muscle,
which proliferate as suspended clusters of cells (myospheres). These
cells express the myogenic markers MyoD and desmin, indicating
their commitment to the myogenic lineage. Under appropriate
culture conditions, the myspheres adhere to the plate, start to
spread out and form very thin mygenin and myosin heavy chain
positive contractile fibers (needles). These needles are initially
mononucleated but later fuse and form multinucleated fibers.
When injected into injured muscle, the cells participated in muscle
regeneration and gave rise to mature multinucleated muscle fibers
[16]. We have isolated several clones of such muscle progenitor
cells (MPCs). All of them express myogenic markers and
Myoblasts Transdifferentiation
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analysis and staining for MyoD and desmin confirmed the stable
retention of the myogenic commitment by virtually all cells. PCR
analysis did not detect expression of Oct4, a hallmark of
pluripotent embryonic stem cells.
Since the brain of newborn mice continues to develop during
the first two weeks post partum, we injected the cloned myogenic
cell populations into the lateral ventricles of the brain of three day
old mice, and followed their fate. The cloned cells were obtained
from ROSA26 mice, which ubiquitously express b-gal [16,17],
therefore we first identified the location of the injected cells by X-
gal staining (Fig. 1). One week after the injection, we observed
extensive dispersion of the cells in the brain. Stained cells were
mainly found in the cortex, corpus-callosum, hippocampus, and
few cells were also observed in the thalamus, cerebellum, and the
olfactory bulb. Immunofluorescence labeling with both anti-b-gal
and anti-doublecortin (a marker for immature neurons) revealed a
fraction of cells with a neuronal morphology that expressed both
markers (Fig. 2A–C). Staining for another marker for immature
neurons, b-tubulin-III (Tuj1), together with anti-b-gal, revealed
double stained cells in the corpus callosum and in the CA1 field of
the hippocampus (Fig. 2D–F). Staining for markers of mature
neurons, NF-160 and NeuN also revealed a fraction of cells that
expressed b-gal and the neurogenic marker (Fig. 2G–I). Overall,
between 2000–4000 donor cells (expressing b-gal) were found in
slices of each of the injected brains. About 17% of them expressed
doublecortin, 6% expressed Neurofilament (NF)-160, 3expressed
b-tubulin-III, and 3% expressed NeuN. About 5% of donor cells
expressed the glial fibrillary acidic protein (GFAP) (Figure 3).
Analysis of MyoD expression by the injected cells revealed that
only the cells in the vicinity of the injection site retained its
expression, whereas the cells that spread in the brain and
expressed neuronal markers did not express MyoD (not shown).
Injected Myogenic Cells Express YFP Controlled by a
Neuronal Specific Promoter
We have also cloned myosphere cells from skeletal muscles of
transgenic mice harboring a yellow fluorescent protein (YFP)
transgene under the control of regulatory elements of the Thy1
gene (Thy1-YFPH 2Jrs/J) that confer specificity of YFP expression
to a subset of neurons [18]. The cloned cells (which, like all muscle
cells of the transgenic mice, did not express YFP during
proliferation and differentiation in cell cultures), were injected
into the brain lateral ventricles of newborn C57BL mice. After one
week, the injected brains were sliced and examined (without
immunostaining) for the expression of YFP. We found that the
pattern of distribution of injected cells that expressed YFP was very
similar to that of myosphere cells co-expressing the neuronal
markers and b-gal, described above (Fig. S1). This further supports
the conclusion that myogenic progenitor cells are induced to
express neuronal genes in the developing mouse brain.
Human Myogenic Cells Spread in the Mouse Brain and
Express a Human Neuronal Marker
Using an adaptation of a differential pre-plating technique [8]
we obtained from human muscle, cultures consisting of almost
pure populations of MyoD expressing myogenic cells. These cells
proliferate as a monolayer of myoblasts, which later fused into a
network of multinucleated fibers. A myogenic clone isolated from
such a culture (Figure 4) was used to test the capacity of human
derived mononucleated myoblasts to give rise to neurogenic cells
following injection to the brain of three day old mice. The cells
were labeled with Hoechst dye prior to injection, and as described
for mouse myosphere cells experiments, the inoculated brains were
fixed and sectioned 5 and 9 days following injections. Sections
showing Hoechst labeling were stained with an antibody specific
for the human NF-70. The injected cells spread in the brain and
were mostly localized close to the ventricles, in the subventricular
zone (SVZ), and along the corpus callosum, in a pattern very
similar to the lateral cortical stream (LCS) of migration of innate
neurons, that occurs during embryogenesis [21]. The number of
brain cells expressing human NF-70 was greater in the brains
collected 9 days following injection (Figure S2) than in brains
collected 5 days following injection.
These results show that like mouse myoblasts, also human
myogenic cells migrate in the developing mouse brain and express
a human neuronal marker, pointing at the generality of the
phenomenon and its possible potential clinical application.
Furthermore, since the human cell preparations consisted of
cloned populations derived from conventional primary myoblast
cultures, these data demonstrate that the conversion of myogenic
cells to neuronal cells is not restricted to cells derived from
myospheres.
Transdifferentiation of Myogenic Cells to Neurogenic
Cells Does Not Depend on Fusion with Host Cells
Several earlier studies, demonstrating the incorporation of
donor cells in host tissues and transdifferentiation, were explained
by fusion of donor and host cells and the formation of
Figure 1. X-Gal staining of brains injected with cloned myosphere cells. Cloned MyoD positive myosphere cells (MPCs), obtained from
ROSA26 mice, were injected into the lateral ventricles of the brain of newborn mice. Mice were sacrificed after 2 days (A), and 7 d (B) and their brains
were removed. X-Gal staining was performed on the whole brain (in A), and on brain slices (in B). Two days after injection, the cells were still localized
in the ventricle, in a compact cluster, while few cells started to migrate out of the ventricle (A). After seven days, the cells were detected as single blue
cells in several brain regions, including the corpus callosum (B) Magnifications: A, 640; B, 6200.
doi:10.1371/journal.pone.0008814.g001
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myogenic cells expressing neuronal markers contained only one
normal looking nucleus. Only about 2% of the double-labeled cells
had two nuclei or an aberrant nucleus. This suggested that the
expression of the neurogenic markers in donor-derived cells was
not the result of fusion with host cells.
Consistent with this, when we injected human myoblasts into
the brain of three day old mice ubiquitously expressing GFP,
almost all donor cells that expressed human NF-70 did not express
GFP (Fig. 5).
To investigate the question of cell fusion more rigorously, we
inoculated the cloned myosphere cells derived from the Thy1-YFP
transgenic mice (described above) into the brains of 3 day old wt
mice. One week later,the brainsweredissociated,and the cells were
labeled with Hoechst, to measure their DNA content. Approxi-
mately 500 YFP expressing cells were sorted by FACS, and
analyzed for their DNA content. Cell cycle analysis of these cells
revealed that the DNA content of the donor derived YFP expressing
cell population was very similar to that of the main population
(Fig. 6). There was no evidence for a peak that indicates tetraploidy.
This result indicates that the expression of neuronal traits by the
cells of donor origin was mainly not due to fusion with host cells,
thereby implying a genuine transdifferentiation of the injected cells,
which was induced by the host environment.
Discussion
Experiments with cloned mammalian cells demonstrated the
very stable retention of differentiation programs during extended
periods of cell proliferation in culture. In contrast, cell fusion,
nuclear transplantation, and forced expression of transcription
factors, demonstrated the plasticity of nuclei of differentiated cells
[1,22–25]. However, the question is still open of whether intact
genetically unmodified somatic cells, committed to specific
differentiation fates, can be reprogrammed in vivo by host ectopic
micro-environment [e.g. 2–6, 26, 27]. The major controversial
questions are a) the possible heterogeneity of the donor cell
population and b) whether it is a genuine induction process that
occurs in response to the host environment, or a result of fusion
between host and donor cells. We addressed these questions using
cloned myogenic progenitor cells, committed to the myogenic
lineage. Injection of such cells into the brain of mice ubiquitously
expressing GFP enabled us to determine whether cells that express
both the donor marker and neuronal markers, also express the
host specific GFP protein. Using another approach we measured
the DNA content of sorted donor cells expressing YFP controlled
by a neuronal specific promoter, and compared their DNA
content with that of the main brain population. Both techniques
indicated that most transdifferentiated cells did not fuse with
host cells.
Figure 2. MPCs express neurogenic markers following inoculation into the brain of newborn mice. Brains were injected as described in
Figure 1. A–F, seven days later the brains were fixed and sliced. A–C, a cell expressing both the donor marker, b-gal (red) and the early neuronal
marker Doublecortin (green). D–F, cells expressing both b-gal (red) and early neuronal marker b-III-tubulin (Tuj1) (green). Arrows indicate double-
labeled cells in the CA1 region of the hippocampus. G–I, Brains collected 2 weeks after injection. G, Double-immunostaining with anti-b-gal (red) and
anti-mature neuronal marker NF-160 (green) revealed yellow stained cells that expressed both markers (arrows). Arrowheads in G indicate cells that
express b-gal and not NF-160. H–I, X-Gal stained slices (blue) incubated with anti-NeuN antibody (mature neuronal marker). Labeling was detected
using peroxidase staining (brown). Arrows indicate cells that express both NeuN and b-gal. Magnifications: A–C, G6400; D–F, H–I,6200. Arrowhead
indicates a cell that expresses b-gal but not NeuN.
doi:10.1371/journal.pone.0008814.g002
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the process. Two days after the injection, the majority of the cells
still remained in the ventricle. A massive migration out of the
ventricle occurred at the fourth day (not shown), and peaked at the
seventh day. The highest percentage of donor cells expressing
neuronal markers was observed 7 days and 9 days post injection.
Two weeks after injection, there was a decrease in the frequency of
donor cells. Brains analyzed 30 days post injection revealed a
further reduction in the frequency of donor cells (not shown). The
reason for this apparent reduction is unknown. Although ROSA
26 mice are on a C57BL/6 background and the brain is a
relatively immunological privileged site, an immunologic reaction
cannot be excluded. This observation needs further investigation.
The rarity of the donor cells rendered it impossible to test their
electrophysiological activity in vivo. However, immunocytochem-
ical examination demonstrated the presence of donor-derived cells
expressing markers of mature neurons, such as NF-160 and NeuN,
and many of the cells gained a neuronal morphology. This
suggests that at least a fraction of these cells reached neuronal
maturity.
In view of recent progress in the refinements of culture
conditions for controlling the differentiation of embryonic and
adult stem cells in vitro, it is of obvious interest to search for
conditions that recapitulate in cell culture the conversion of
myogenic cells to neurogenic cells and to test the functionality of
the transdifferentiated cells, as indicated by their capacity to form
neuromuscular junctions and by recording their electrophysiolog-
ical activity.
The present investigation suggests that the developing brain
emits signals that stimulate cell migration and transdifferentaion of
the donor derived cells. It is of interest to note that inoculation of
myosphere cell populations into adult brain resulted in very little
donor cell migration and undetectable transdifferentiation.
However, myosphere cells inoculated into the damaged brain of
Experimental Autoimmune Encephalitis (EAE) affected mice, the
mouse model of multiple sclerosis, did spread in the brain and
a fraction of them gained neuronal morphology and expressed
neuronal markers [28]. This suggests that the regenerating brain
(but not normal adult brain) emit a signal or signals with similar
functions. Moreover, the present study indicates that human
myoblasts respose to the mouse signal.
Sigurjonsson et al., [29] reported that engrafting of CD34+
adult human hematopoietic cells in close proximity to an injured
spinal cord of a developing chick embryo, resulted in the efficient
participation of the human derived cells in the regeneration of the
chick embryo spinal cord, and their transdifferentation into
functional neuronal cells. This suggests the wide-spread and
strong evolutionary conservation of such signals.
In addition to the basic biological aspects, the migration of
inoculated human myoblasts in the brain, and the expression of
neuronal markers by a fraction of them, suggest a possible
therapeutic potential, leading to the use of innate genetically
unmodified myoblasts for autologous cell therapy of diseases of the
CNS. The possibility to reprogram somatic cells into iPS cells,
closely resembling embryonic stem cells, raised great hopes for a
customized cell therapy approach, using autologous somatic cells
converted into stem cells. Recent studies indicate that induction of
pluripotency can also be done by exposing intact genetically
unchanged somatic cells to chimeric transcription factors that
penetrate the cells and induce an epigenetic reprogramming
process leading to pluripotency [30,31]. However, one of the main
problems which may hamper these approaches is the tumorigenic
potential of pluripotent cells [e.g. 32–35]. The present study
supports the claim that committed somatic cells can be induced to
transdifferentiate in vivo into a different cell lineage phenotype by
ectopic environmental signals, thus, circumventing the use of
embryonic stem cell like cells for autologous cell therapy. The
short time it takes for the implanted donor cells to express
neuronal markers, suggests a direct conversion of the myogenic
cells into neuronal phenotype without the involvement of an
embryonic stem cell state.
Supporting Discussion
Steffel et al., [36] reported that cells of the myogenic line C2,
injected into the brain of rat embryos contributed to mesodermal
Figure 4. Cloned human myogenic cells. The culture was prepared
as described in Method, grown for 10 days in the growth medium
(BioAmf-2) and then induced to fuse and differentiate by changing to
DMEM containing 10% horse serum, and insulin (4 units/100 ml). After
7 days the cells were fixed with methanol and stained with Giemsa.
Note massive cell fusion. (Cells for inoculation into the developing
mouse brains were collected before the change to the fusion inducing
medium).
doi:10.1371/journal.pone.0008814.g004
Figure 3. Quantification of brain inoculated MPCs expressing
both donor b-gal and CNS cells marker. Double immunolabled
cells were counted for each of the indicated antibodies. The bars
describe the % of double-labeled cells, out of the detected, donor
derived b-gal expressing cells that spread in the brain.
doi:10.1371/journal.pone.0008814.g003
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brains of mice ubiquitously expressing GFP. After 9 days, the brains were sliced and immunostained with a human specific anti-NF-70 antibody (red).
Donor cells expressinghumanspecificNF-70 protein (A). Mergeimagesshowedthat these cellsdonotexpress the hostGFPprotein (B). C,D, Rare fusion
events, usually resulted in the formation of a small cluster of bright yellow aberrant figures in the merged picture (D). Magnifications: 6200.
doi:10.1371/journal.pone.0008814.g005
Figure 6. The DNA content of donor-YFP expressing cells is very similar to the DNA content of host diploid brain cells. Brains of wild
type C57BL 3 day old mice were injected with myogenic clones derived from transgenic mice expressing YFP under the control of a neuronal specific
promoter (Fig. S1). One week following injection the brain cells were suspended, labelled with Hoechst, and sorted by FACS. (A) The main population,
containing brain cells that do not express YFP. (B) Cells expressing YFP. (C–E), Cell cycle analysis of the cells collected in A and B. The peak of the G1-
G0 cells of the main population (C) and the pack of the G1-G0 cells of the YFP expressing cells (D) have the same value of Hoechst staining. The
histogram of the YFP expressing cells was normalized to that of the main population, and overlapped, to demonstrate the very similar value of the
G1-G0 populations (E). The 4n arrow indicates the calculated DNA value for tetraploid nuclei.
doi:10.1371/journal.pone.0008814.g006
Myoblasts Transdifferentiation
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neurogenic lineage was observed. In addition to the neuronal
differentiation, described above, we also observed the incorpora-
tion of a fraction of injected cells into the brain vasculature (not
shown). The difference between those results and the present study
might be due to the difference in the donor cells (C2 vs
myospheres cells) or in the nature of the host environment (i.e.
embryonic rat brain vs newborn mouse brain).
Supporting Information
Figure S1 Activation of a transgenic neuronal specific promoter
in transgenic donor MPCs injected into the brain of wild-type,
new-born mice. Cloned myosphere cells obtained from the Thy1-
YFP transgenic mice were injected into the brains of 3 day old
C57BL mice. The brains were removed one week following
injection and sliced; selected slices were screened for the
expression of YFP using fluorescence microscope. Part of the
injected cells expressed YFP, thereby indicating that the neuron
specific promoter was activated in those donor cells. The pattern
of the distribution of these cells was very similar to the pattern
observed with either X-Gal or b-gal immunoflourescence stain-
ings. Nuclei were stained with DAPI. A,B, corpus-callosum, C,D,
hippocampus. Magnifications: A-C, 6200; D, 6400.
Found at: doi:10.1371/journal.pone.0008814.s001 (6.92 MB TIF)
Figure S2 Human myogenic cells migrate in the brain of
newborn mice and express a human specific neuronal marker.
Cloned human myogenic cells were labeled with Hoechst dye
(blue) and injected into the lateral ventricles of newborn mice.
Brains were removed after 9 days, fixed and sliced. The injected
cells were localized mostly in the cortex, subventricular zone, and
corpus callosum (A). Selected slices were immunostained with
antibody specific to human NF-70. B-C donor injected cells
expressing human specific NF-70 (green). D-E- higher magnifica-
tions of B-C. IS- injection site, SVZ-subventricular zone, CC-
corpus callosum.
Found at: doi:10.1371/journal.pone.0008814.s002 (3.88 MB TIF)
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